Motion Sickness on Astrolabe's Vessel

NCT02911402 | Completed

• 1 other identifier: 14-153
• Study Type: observational
• Target: 147
• Locations: 1 country
• Sites: 1

Brief Summary

Sea sickness syndrome is present for 80% of persons on board when the boat rotation missions Astrolabe, sometimes there is a risk of very significant dehydration. A special unit specialized in the fundamental study of the vestibular system (inner ear), sensory organ at the base of visual-vestibular conflict inducing this syndrome, also provides medical support for parabolic flights (flight reproducing weightlessness) where this syndrome is strongly present. The goal of the study is to assess the frequency of occurrence of this sea sickness syndrome on the Astrolabe, to understand the triggers (type of boat movements, personality traits, anxiety / stress) without changing habits on board for those on board taking a antinaupathique treatment given by the ship's doctor. This study will be done in collaboration between INSERM U 1075 (France) and the Laboratory of military research VIPER specialized in extreme environments (Belgium). The ultimate goal will be to provide the best recommendations and the best treatment regimen to alleviate as best as possible the symptoms of people on board of the Astrolabe so scientists on board can perform their work.

Conditions

Sea Sickness

Outcome Measures

Primary Outcomes (6)

• Motion Sickness susceptibilty questionnaire (fMSSQ)

  Sensitivity of motion sickness

  day 1 to day 10

• STAY-YA questionnaire

  anxiety

  day 1 to day 10

• STAY-YB questionnaire

  anxiety

  day 1 to day 10

• Vis-Morgen Questonnaire about sleeping

  Subjective sleep scoring

  day 1 to day 10

• Fatigue questionnaire

  Tiredness

  day 1 to day 10

• Dietary intake survey

  food intake

  day 1 to day 10

Secondary Outcomes (5)

• type of movement from the ship using use the data from the Dynamic Positioning System on board

  baseline and every day up to 10 days

• data from individual actigraphs worn by the participants

  baseline and every day up to 10 days

• personnality questionnaire (OCEAN)

  baseline and every day up to 10 days

• anxiety questionnaire (STAY).

  baseline and every day up to 10 days

• treatment taken (international denomination and dose)

  baseline and every day up to 6 days

Interventions

sea sickness questionnaires OTHER

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Astrolabe passengers

You may qualify if:

• participant aged of 18 or older but younger than 70 who received their medical ability to travel to Terre Adélie or making a research cruise aboard the Astrolabe
• particpant signing the informed consent.

You may not qualify if:

• none

Sponsors & Collaborators

• University Hospital, Caen: lead

Study Sites (1)

Caen University Hospital

Caen, 14033, France

Location

MeSH Terms

Conditions

Motion Sickness

Condition Hierarchy (Ancestors)

Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• stephane Besnard, MD

  CaenHU

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 20, 2016
• First Posted: September 22, 2016
• Study Start: October 1, 2014
• Primary Completion: December 1, 2017
• Study Completion: December 1, 2018
• Last Updated: February 15, 2022

Record last verified: 2022-01

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)